Navigation Links
Bacterin Announces Record 2011 Revenue of $30.1 Million; Up 96% Year-over-Year
Date:3/22/2012

www.bacterin.com/index.htm">http://www.bacterin.com/index.htm.

Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Hayden IR at 1-646-755-7412.

A replay of the call will be available after 7:30 p.m. Eastern time on the same day and until April 22, 2012.

About the Presentation of EBITDAEBITDA is not a financial measure calculated and presented in accordance with U.S. generally accepted accounting principles (GAAP) and should not be considered as an alternative to net income, operating income or any other financial measures so calculated and presented, nor as an alternative to cash flow from operating activities as a measure of liquidity. The company defines EBITDA as net income/(loss) from operations before depreciation, amortization and non-cash stock-based compensation. Other companies (including competitors) may define EBITDA differently. The company presents EBITDA because management believes it to be an important supplemental measure of performance that is commonly used by securities analysts, investors and other interested parties in the evaluation of companies in our industry. Management also uses this information internally for forecasting and budgeting. It may not be indicative of the historical operating results of Bacterin nor is it intended to be predictive of potential future results. Investors should not consider EBITDA in isolation or as a substitute for analysis of the company's results as reported under GAAP. See "GAAP to non-GAAP Reconciliation" below for further information on this non-GAAP measure. Bacterin International Holdings, Inc.Reconciliation of Net (Loss) Income From Operations to EBITDA(Unaudited)Three Months Ended Three Months Ended Twelve Months Ended Twelve Months Ended 31-Dec-1131-Dec-1031-Dec-11

31-Dec-10Net Loss from operations

(2,
'/>"/>

SOURCE Bacterin International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Bacterin International Holdings, Inc. Schedules Fourth Quarter 2011 Financial Earnings Conference Call
2. Bacterin Signs Distribution Agreement with Jeil for LeForte Craniomaxillofacial System
3. Bacterin Becomes Premier Founding Sponsor of RMECs New Osteobiologics Registry
4. Bacterin to Present at Lazard Capital Markets 8th Annual Healthcare Conference on November 16, 2011
5. Bacterin Sponsors the 2012 Donate Life Rose Parade Float in Recognition of Donor Families
6. Bacterin International to Present at Stifel Nicolaus 2011 Healthcare Conference on September 8, 2011
7. Bacterin Reports New Hires and Management Reorganization, Driving Most Active Processing Month in July
8. Bacterin International Signs Its Second National GPO Contract for Bacterin Biologics and Its First For Wound Drains with ROi
9. Bacterin International to Present at Noble Financial Capital Markets Seventh Annual Equity Conference on May 16, 2011
10. Bacterin International Secures $1.9 million in Private Placement
11. Bacterin International Updates Fourth Quarter and Full Year 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... DIEGO AND TORONTO, May 5, 2015 /PRNewswire/ - Aptose Biosciences ... today reported financial results for the three months ended ... specified otherwise, all amounts are in Canadian dollars. ... its fiscal year end from May 31 to December ... interim period being reported is for the three months ...
(Date:5/5/2015)... VetStem Biopharma, proudly announces former ... Schaffer, DVM, as Director of Veterinary Professional Services. ... experience in the veterinary regenerative medicine field Dr ... veterinarian lead organization”. Dr. Alexis Nahama, President ... be responsible for all technical activities in relationship ...
(Date:5/5/2015)... Mass. , May 5, 2015 Psyche ... strategic alliance which offers a first-of-its-kind platform that helps ... access to lab results, transforms the way patients engage ... Luminate Health provides a HIPAA-compliant digital ... to access, manage, and understand their lab results, and ...
(Date:5/5/2015)... May 5, 2015  Renova™ Therapeutics, a biopharmaceutical ... failure and other chronic diseases, has engaged RAND ... designed to reflect the healthcare patterns of multiple ... will be used to characterize the impact the ... on those groups of patients and the overall ...
Breaking Biology Technology:Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 2Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 3Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 4Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 5Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 6Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 7Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 8Leading Regenerative Veterinary Medicine Company, VetStem Biopharma announces the addition of Dr Jeffrey Schaffer as the Director of Veterinary Professional Services. 2Psyche Systems Corporation Forms Strategic Alliance with Luminate Health to Provide First-of-its-kind Patient Access Solution 2Psyche Systems Corporation Forms Strategic Alliance with Luminate Health to Provide First-of-its-kind Patient Access Solution 3RAND Health Advisory Services modeling heart failure patient outcomes to inform potential impact of Renova Therapeutics lead product candidate 2RAND Health Advisory Services modeling heart failure patient outcomes to inform potential impact of Renova Therapeutics lead product candidate 3
... , GAITHERSBURG, Md., Aug. 6 GenVec, Inc. (Nasdaq: ... quarter ended June 30, 2009. , , ... GenVec reported a net loss of $4.8 million ($0.05 per ... net loss of $6.6 million ($0.08 per share) in the comparable quarter ...
... , ROCKVILLE, Md., Aug. 6 Novavax, Inc. ... Frederick W. Driscoll as Vice President, Chief Financial Officer and ... Novavax,s President and Chief Executive Officer. , , ... President and Chief Executive Officer of Genelabs Technologies, Inc. ...
... , NEWTON, Mass., Aug. 6 Microfluidics International ... release second quarter 2009 financial results on Tuesday, August 11, ... , Michael C. Ferrara, President and Chief Executive Officer, ... Officer, will host a conference call and live audio webcast at ...
Cached Biology Technology:GenVec Reports Second Quarter 2009 Financial Results 2GenVec Reports Second Quarter 2009 Financial Results 3GenVec Reports Second Quarter 2009 Financial Results 4GenVec Reports Second Quarter 2009 Financial Results 5GenVec Reports Second Quarter 2009 Financial Results 6GenVec Reports Second Quarter 2009 Financial Results 7Novavax Announces Appointment of Frederick W. Driscoll as Vice President, Chief Financial Officer and Treasurer 2Microfluidics International Corporation to Report Second Quarter 2009 Financial Results on August 11, 2009 2
(Date:3/23/2015)... March 23, 2015 SoundView Technology Group issues a ... NXTD ) Wocket smart wallet. SoundView was one of the ... their experience with the Wocket in multiple scenarios and outlets. ... Foods and other retailers, making both debit and credit card ... also says, "If the company meets their plans in 2015, ...
(Date:3/23/2015)... March 23, 2015  In the 2014 fiscal year, ... conviction losses. This figure accounts for a fraction of ... The Nilson Report, exceeds $11 billion globally. The polygraph ... a crime has occurred. Investor Mark Saint Juste ... Joe Paolella partnered to administer the test ...
(Date:3/20/2015)... 2015 Research and Markets ( ... "India Sensors Market Forecast and Opportunities 2020" ... sensor market is projected to grow at a ... electronics, automotive, industrial and healthcare sectors are the ... In addition, adoption of MEMS technology in sensors ...
Breaking Biology News(10 mins):Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3
... of Sheffield, has accurately measured for the first time the ... scientists to make more accurate predictions concerning the impact of ... will be published today (5 July 2010) in the journal ... and carbon data from around the world to assess Gross ...
... This release is available in Spanish . , ... the animals, eye color, according to an Agricultural Research Service ... Dale Bumpers Small Farms Research Center in Booneville, Ark., and ... with scientists, veterinarians, and extension agents from the Southern Consortium ...
... IDenta Corp.,(PINKSHEETS: IDTA) CEO Yaacov Shoham today issued a statement concerning the,BTK-Bullet hole test kit. , ... The IDenta,s BTK- Bullet Hole Testing Kit was mentioned in news articles,on the Las Vegas ... To see the article, click on the links below: , ... http://www.lasvegassun.com/news/2008/jul/08/gee-whiz-packed-metro-csi-tru , , , ...
Cached Biology News:Research helps predict future impact of climate change 2For lambs, a pasture a week keeps blood suckers away 2International Drug & Explosives Detection Company IDenta Corp Reports on BTK- Bullet Hole Testing Kit 2International Drug & Explosives Detection Company IDenta Corp Reports on BTK- Bullet Hole Testing Kit 3
Request Info...
Agarose-LE, 250 g. Suitable for soft agarose cloning. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1200 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
IC50: 3 ng/ml · Limit of detection: 0.9 ng/ml...
Request Info...
Biology Products: